An innovation in portable ERG/VEP electroretinography that is transforming the way retinal and optic nerve diseases are diagnosed and managed. 

RETeval® is the ideal solution for those seeking superior diagnostic accuracy, both for clinical and research use.

RETeval® offers simple use and easy-to-interpret results, in a portable and lightweight device, suitable for patients of all ages without the need for sedation. 

Its full-field Ganzfeld feature in a portable ERG/VEP format and patented Sensor Strip skin electrodes ensure a non-invasive approach without corneal contact.

Another significant advantage is real-time pupillography, which allows use in non-dilated patients, further simplifying the testing process.

For ophthalmologists, RETeval® offers access to entered and processed data with the ability to customize protocols, making it a valuable tool for advanced research thanks to its portability and consistent results.

RETeval® is essential not only for early detection of diseases such as diabetic retinopathy, glaucoma and hereditary retinal dystrophies, but also for predicting disease progression and monitoring the effectiveness of treatment. 

Its easy-to-interpret reports, compared with a reference data set profiled by age, make RETeval® an indispensable tool for efficient diagnosis.

RETeval® is designed to provide critical diagnostic information with precision and ease.

To find out how RETeval® can transform the practice of electroretinography in your environment, contact us. 

We are here to take you into the future of ophthalmology with the most advanced solutions.